Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-news-1/a-birds-eye-view-of-art-9072-2/;msg18067;topicseen) was not found.

Search biology news 1 a birds eye view of art 9072 2 ;msg18067;topicseen at Google

Search biology news 1 a birds eye view of art 9072 2 ;msg18067;topicseen at Yahoo

Search biology news 1 a birds eye view of art 9072 2 ;msg18067;topicseen at Msn

Google
 
(Date:11/6/2009)...with their arboreal hosts. But new research sugges...of choice, the ants can get destructive to neighbo...ember issue of the American Naturalist , is the f...nd it reopens a centuries-old debate on the relati...in species of plants and trees have cozy relations...
(Date:11/5/2009)...ning grant in the amount of $2,756,719 by the Nati...uation Education and Research Training (IGERT) pro...to Kent State. The grant, which is funded under th...runs through 2014. , The grant funds an IGERT pr... sensing (EARS). The purpose of the program is to ...
(Date:11/4/2009)... hold the power to help militaries and munitions m...c waste on test sites. , Compounds known as nitr...rld War II and have been used in military munition...ten used to propel tank shells and act like a more... knowledge of their environmentally harmful effect...
Breaking Biology News(10 mins):Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Genomic research will enable greener cleanup of military explosive test sites 2Switching early breast cancer patients to exemestane improves long term survival 57884 1Switching early breast cancer patients to exemestane improves long term survival 57884 2Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 1Prince Albert II of Monaco Foundation helps fund Field Museum conservation efforts in Peru 10013 2Julio Palmaz to Present at the 2009 TCT Conference 57879 1Julio Palmaz to Present at the 2009 TCT Conference 57879 2
(Date:11/9/2009)... Omnetics Connector Corporation announces t...een certified. , Minneapo...ctor Corporation, the leading manufacturer of mini...sign, production and QA systems have been certifie...n B, International Quality System Standard., , ,Th...
(Date:11/9/2009)... -- Gifted young athletes are under increasing pre... new Loyola University Health System study of 519 ...zation increases the risk of injury. Researchers w...Association junior competition found that players ... withdraw from tournaments for medical reasons, ty...
(Date:11/8/2009)...gislation would strengthen Medicare, improve cover...ewswire-USNewswire/ -- SUMMARY: Yesterday the Un...al health care reform legislation that would stren...by insurance companies that prices millions of Ame...The Affordable Health Care for America Act (H.R. 3...
(Date:11/8/2009)...can take you out of the game later, doctors say ,...t injuries are the talk of the NFL this season, si... running back Willie Parker. , Officials at the...an Academy of Podiatric Sports Medicine are warnin...ay fall sports like football and lacrosse. , "M...
(Date:11/8/2009)... 3D Global Solutions is pleased to announce...he proposal effort for ReSound who recently receiv... Aid contract. The award includes not only the Vet...efense and other federal agencies. , ...-- 3D Global Solutions is pleased to announce that...
Breaking Medicine News(10 mins):Health News:Omnetics Connector Corporation Achieves AS9100 Certification 2Health News:Young tennis players who play only 1 sport are more prone to injuries 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 2Health News:AARP NY Praises House Passage of Health Care Reform Bill 3Health News:AARP NY Praises House Passage of Health Care Reform Bill 4Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3
Finnpipette BioControl Multichannel, 8 Channel 5-50ul from Thermo Scientific
Acl I (Psp1406 I) from New England Biolabs
Mouse Anti-Human Cystatin A Monoclonal Antibody, Unconjugated, Clone 224705 from R&D Systems
Acc I from Takara Mirus Bio
Biology Products:
AgileTrac™ Patient Flow
Radianse Indoor Positioning Patient Location
... BD Vacutainer Eclipse Blood Collection Needle con...le integrated with a safety shield aligned to the ...VERY BD Vacutainer Eclipse Blood Collection Needle...need to attach a secondary safety accessory. Immed...
Diana incubator
Medicine Products:
(Date:11/6/2009)...Intarcia Therapeutics, Inc. delivered two presenta...s delivery of exenatide) program for the treatment...echnology Meeting in San Francisco, CA: ,, (Log...FTU126LOGO ) ,, Continuous Subcutaneous Deliv...e, HbA1c and Reduces Weight in a 28-day Phase 1b S...
(Date:11/5/2009)... DSM Pharmaceutical Products today announced that ... Saint Jean D,Illac, France, where DSM will be the...for Galenix commercial products on a global basis....s development opportunities co-marketing Galenix d...f Galenix in drug product development and clinical...
(Date:11/5/2009)...Call/ -- BioSpecifics Technologies Corp. (Nasdaq: ...rst-in-class collagenase-based products, today ann... ended September 30, 2009. ,, "We were extreme...s Arthritis Advisory Committee unanimously recomme...M) for the treatment of Dupuytren,s disease, and w...
(Date:11/5/2009)...ineSmith Partners has signed an initial agreement ...d that mimics the structure of natural cancellous ...products by SpineSmith,s Research and Development ...fold represents a significant advancement in techn...for the delivery of adult stem cells for skeletal ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
(Date:11/6/2009)...e-FirstCall/ -- Caraco Pharmaceutical Laboratories...romethamine ophthalmic solution, 0.5% following a ...ation (FDA) for Sun Pharma,s Abbreviated New Drug ...lmic solution on the first day following patent ex...cally equivalent to Acular® Ophthalmic Soluti...
(Date:11/6/2009)...ire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA ),...oducts for minimally disruptive surgical treatment...f Michael J. Lambert as Executive Vice President a...2009. The Company also announced several other Ex...ll be an excellent complement to the NuVasive fami...
(Date:11/6/2009)...ire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq:...evelopment of small-molecule therapeutics for the ...cy virus (HIV), today reported recent accomplishme...d nine months ended September 30, 2009. ,, (Lo.../ARDEALOGO ) ,, "Since our last quarterly updat...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8Regence Worksite Wellness Program Pays Off 57874 1Regence Worksite Wellness Program Pays Off 57874 2Immune Cells Offer Hope for Injured Lungs 57870 1Immune Cells Offer Hope for Injured Lungs 57870 2Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency 57865 1Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency 57865 2Bionovo Notified by NASDAQ of Minimum Bid Price Deficiency 57865 3